trending Market Intelligence /marketintelligence/en/news-insights/trending/LXSBN0y8NC3IamF27vFCmA2 content esgSubNav
In This List

Novelion Therapeutics appoints board member

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Novelion Therapeutics appoints board member

Novelion Therapeutics Inc. appointed Mark Corrigan to its board of directors.

Corrigan is the former CEO and president of Zalicus Inc. He currently serves on the board of Cardiome Pharma Corp. and on the supervisory board of Nabriva Therapeutics AG.